Loading…

Enhanced retroviral transduction of 5-fluorouracil-resistant human bone marrow (stem) cells using a genetically modified packaging cell line

Pluripotent hematopoietic stem cells (PHSC) are rare cells capable of multilineage differentiation, long-term reconstituting activity and extensive self-renewal. Such cells are the logical targets for many forms of corrective gene therapy, but are poor targets for retroviral mediated gene transfer o...

Full description

Saved in:
Bibliographic Details
Published in:Blood 1998-12, Vol.92 (11), p.4080-4089
Main Authors: POVEY, J, WEERATUNGE, N, MARDEN, C, SEHGAL, A, THRASHER, A, CASIMIR, C
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1723-b98cf0b32a3e2a9c3a10dda05a86e4f848eefaa5802d2596844e71c184cf680a3
cites cdi_FETCH-LOGICAL-c1723-b98cf0b32a3e2a9c3a10dda05a86e4f848eefaa5802d2596844e71c184cf680a3
container_end_page 4089
container_issue 11
container_start_page 4080
container_title Blood
container_volume 92
creator POVEY, J
WEERATUNGE, N
MARDEN, C
SEHGAL, A
THRASHER, A
CASIMIR, C
description Pluripotent hematopoietic stem cells (PHSC) are rare cells capable of multilineage differentiation, long-term reconstituting activity and extensive self-renewal. Such cells are the logical targets for many forms of corrective gene therapy, but are poor targets for retroviral mediated gene transfer owing to their quiescence, as retroviral transduction requires that the target cells be cycling. To try and surmount this problem we have constructed a retroviral producer line that expresses the membrane-bound form of human stem cell factor (SCF) on its cell surface. These cells are capable, therefore, of delivering a growth signal concomitant with recombinant retroviral vector particles. In this report we describe the use of this cell line to transduce a highly quiescent population of cells isolated from adult human bone marrow using the 5-fluorouracil (FU) resistance technique of Berardi et al. Quiescent cells selected using this technique were transduced by cocultivation with retroviral producers expressing surface bound SCF or with the parent cell line that does not. Following coculture, the cells were plated in long-term bone marrow culture for a further 5 weeks, before plating the nonadherent cells in semisolid media. Colonies forming in the semisolid media over the next 14 days were analyzed by polymerase chain reaction for the presence of the retroviral vector genome. Over six experiments, the transduction frequency of the quiescent 5-FU resistant cells using the SCF-expressing producer line averaged about 20%, whereas those transduced using the parent producer line showed evidence of reduced levels or no transduction.
doi_str_mv 10.1182/blood.V92.11.4080
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_V92_11_4080</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>9834213</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1723-b98cf0b32a3e2a9c3a10dda05a86e4f848eefaa5802d2596844e71c184cf680a3</originalsourceid><addsrcrecordid>eNpFkM1uFDEQhC1EFJbAA3BA8oEDHGZp_8ys54ii8CNFyiXhOurxtDcGj72yZ4jyDjw0XrKCU6tVXdWqj7E3ArZCGPlxDClN2--9rOtWg4FnbCNaaRoACc_ZBgC6Rvc78YK9LOUHgNBKtufsvDdKS6E27PdVvMdoaeKZlpx--YyBLxljmVa7-BR5crxtXFhTTmtG60OTqfiyYFz4_Tpj5GOKxGfMOT3w92Wh-QO3FELha_Fxz5HvKdLiLYbwyOc0eefrvwPan7g_HhyPefCRXrEzh6HQ69O8YHefr24vvzbXN1--XX66bqzYSdWMvbEORiVRkcTeKhQwTQgtmo60M9oQOcTWgJxk23dGa9oJK4y2rjOA6oKJp1ybUymZ3HDIvhZ4HAQMR7DDX7BDBVvX4Qi2et4-eQ7rONP0z3EiWfV3Jx1LbeoqQuvL_-BO1JBe_QGwgIVK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Enhanced retroviral transduction of 5-fluorouracil-resistant human bone marrow (stem) cells using a genetically modified packaging cell line</title><source>ScienceDirect - Connect here FIRST to enable access</source><creator>POVEY, J ; WEERATUNGE, N ; MARDEN, C ; SEHGAL, A ; THRASHER, A ; CASIMIR, C</creator><creatorcontrib>POVEY, J ; WEERATUNGE, N ; MARDEN, C ; SEHGAL, A ; THRASHER, A ; CASIMIR, C</creatorcontrib><description>Pluripotent hematopoietic stem cells (PHSC) are rare cells capable of multilineage differentiation, long-term reconstituting activity and extensive self-renewal. Such cells are the logical targets for many forms of corrective gene therapy, but are poor targets for retroviral mediated gene transfer owing to their quiescence, as retroviral transduction requires that the target cells be cycling. To try and surmount this problem we have constructed a retroviral producer line that expresses the membrane-bound form of human stem cell factor (SCF) on its cell surface. These cells are capable, therefore, of delivering a growth signal concomitant with recombinant retroviral vector particles. In this report we describe the use of this cell line to transduce a highly quiescent population of cells isolated from adult human bone marrow using the 5-fluorouracil (FU) resistance technique of Berardi et al. Quiescent cells selected using this technique were transduced by cocultivation with retroviral producers expressing surface bound SCF or with the parent cell line that does not. Following coculture, the cells were plated in long-term bone marrow culture for a further 5 weeks, before plating the nonadherent cells in semisolid media. Colonies forming in the semisolid media over the next 14 days were analyzed by polymerase chain reaction for the presence of the retroviral vector genome. Over six experiments, the transduction frequency of the quiescent 5-FU resistant cells using the SCF-expressing producer line averaged about 20%, whereas those transduced using the parent producer line showed evidence of reduced levels or no transduction.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood.V92.11.4080</identifier><identifier>PMID: 9834213</identifier><language>eng</language><publisher>Washington, DC: The Americain Society of Hematology</publisher><subject>Adult ; Antimetabolites, Antineoplastic - pharmacology ; Biological and medical sciences ; Biotechnology ; Bone Marrow Cells - cytology ; Bone Marrow Cells - physiology ; Drug Resistance, Neoplasm ; Fluorouracil - pharmacology ; Fundamental and applied biological sciences. Psychology ; Gene therapy ; Gene Transfer Techniques ; Genetic Vectors ; Health. Pharmaceutical industry ; Hematopoietic Stem Cells - cytology ; Hematopoietic Stem Cells - drug effects ; Hematopoietic Stem Cells - physiology ; Humans ; Industrial applications and implications. Economical aspects ; Retroviridae</subject><ispartof>Blood, 1998-12, Vol.92 (11), p.4080-4089</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1723-b98cf0b32a3e2a9c3a10dda05a86e4f848eefaa5802d2596844e71c184cf680a3</citedby><cites>FETCH-LOGICAL-c1723-b98cf0b32a3e2a9c3a10dda05a86e4f848eefaa5802d2596844e71c184cf680a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1618039$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9834213$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>POVEY, J</creatorcontrib><creatorcontrib>WEERATUNGE, N</creatorcontrib><creatorcontrib>MARDEN, C</creatorcontrib><creatorcontrib>SEHGAL, A</creatorcontrib><creatorcontrib>THRASHER, A</creatorcontrib><creatorcontrib>CASIMIR, C</creatorcontrib><title>Enhanced retroviral transduction of 5-fluorouracil-resistant human bone marrow (stem) cells using a genetically modified packaging cell line</title><title>Blood</title><addtitle>Blood</addtitle><description>Pluripotent hematopoietic stem cells (PHSC) are rare cells capable of multilineage differentiation, long-term reconstituting activity and extensive self-renewal. Such cells are the logical targets for many forms of corrective gene therapy, but are poor targets for retroviral mediated gene transfer owing to their quiescence, as retroviral transduction requires that the target cells be cycling. To try and surmount this problem we have constructed a retroviral producer line that expresses the membrane-bound form of human stem cell factor (SCF) on its cell surface. These cells are capable, therefore, of delivering a growth signal concomitant with recombinant retroviral vector particles. In this report we describe the use of this cell line to transduce a highly quiescent population of cells isolated from adult human bone marrow using the 5-fluorouracil (FU) resistance technique of Berardi et al. Quiescent cells selected using this technique were transduced by cocultivation with retroviral producers expressing surface bound SCF or with the parent cell line that does not. Following coculture, the cells were plated in long-term bone marrow culture for a further 5 weeks, before plating the nonadherent cells in semisolid media. Colonies forming in the semisolid media over the next 14 days were analyzed by polymerase chain reaction for the presence of the retroviral vector genome. Over six experiments, the transduction frequency of the quiescent 5-FU resistant cells using the SCF-expressing producer line averaged about 20%, whereas those transduced using the parent producer line showed evidence of reduced levels or no transduction.</description><subject>Adult</subject><subject>Antimetabolites, Antineoplastic - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Bone Marrow Cells - cytology</subject><subject>Bone Marrow Cells - physiology</subject><subject>Drug Resistance, Neoplasm</subject><subject>Fluorouracil - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene therapy</subject><subject>Gene Transfer Techniques</subject><subject>Genetic Vectors</subject><subject>Health. Pharmaceutical industry</subject><subject>Hematopoietic Stem Cells - cytology</subject><subject>Hematopoietic Stem Cells - drug effects</subject><subject>Hematopoietic Stem Cells - physiology</subject><subject>Humans</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>Retroviridae</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNpFkM1uFDEQhC1EFJbAA3BA8oEDHGZp_8ys54ii8CNFyiXhOurxtDcGj72yZ4jyDjw0XrKCU6tVXdWqj7E3ArZCGPlxDClN2--9rOtWg4FnbCNaaRoACc_ZBgC6Rvc78YK9LOUHgNBKtufsvDdKS6E27PdVvMdoaeKZlpx--YyBLxljmVa7-BR5crxtXFhTTmtG60OTqfiyYFz4_Tpj5GOKxGfMOT3w92Wh-QO3FELha_Fxz5HvKdLiLYbwyOc0eefrvwPan7g_HhyPefCRXrEzh6HQ69O8YHefr24vvzbXN1--XX66bqzYSdWMvbEORiVRkcTeKhQwTQgtmo60M9oQOcTWgJxk23dGa9oJK4y2rjOA6oKJp1ybUymZ3HDIvhZ4HAQMR7DDX7BDBVvX4Qi2et4-eQ7rONP0z3EiWfV3Jx1LbeoqQuvL_-BO1JBe_QGwgIVK</recordid><startdate>19981201</startdate><enddate>19981201</enddate><creator>POVEY, J</creator><creator>WEERATUNGE, N</creator><creator>MARDEN, C</creator><creator>SEHGAL, A</creator><creator>THRASHER, A</creator><creator>CASIMIR, C</creator><general>The Americain Society of Hematology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19981201</creationdate><title>Enhanced retroviral transduction of 5-fluorouracil-resistant human bone marrow (stem) cells using a genetically modified packaging cell line</title><author>POVEY, J ; WEERATUNGE, N ; MARDEN, C ; SEHGAL, A ; THRASHER, A ; CASIMIR, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1723-b98cf0b32a3e2a9c3a10dda05a86e4f848eefaa5802d2596844e71c184cf680a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Antimetabolites, Antineoplastic - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Bone Marrow Cells - cytology</topic><topic>Bone Marrow Cells - physiology</topic><topic>Drug Resistance, Neoplasm</topic><topic>Fluorouracil - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene therapy</topic><topic>Gene Transfer Techniques</topic><topic>Genetic Vectors</topic><topic>Health. Pharmaceutical industry</topic><topic>Hematopoietic Stem Cells - cytology</topic><topic>Hematopoietic Stem Cells - drug effects</topic><topic>Hematopoietic Stem Cells - physiology</topic><topic>Humans</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>Retroviridae</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>POVEY, J</creatorcontrib><creatorcontrib>WEERATUNGE, N</creatorcontrib><creatorcontrib>MARDEN, C</creatorcontrib><creatorcontrib>SEHGAL, A</creatorcontrib><creatorcontrib>THRASHER, A</creatorcontrib><creatorcontrib>CASIMIR, C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>POVEY, J</au><au>WEERATUNGE, N</au><au>MARDEN, C</au><au>SEHGAL, A</au><au>THRASHER, A</au><au>CASIMIR, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhanced retroviral transduction of 5-fluorouracil-resistant human bone marrow (stem) cells using a genetically modified packaging cell line</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>1998-12-01</date><risdate>1998</risdate><volume>92</volume><issue>11</issue><spage>4080</spage><epage>4089</epage><pages>4080-4089</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>Pluripotent hematopoietic stem cells (PHSC) are rare cells capable of multilineage differentiation, long-term reconstituting activity and extensive self-renewal. Such cells are the logical targets for many forms of corrective gene therapy, but are poor targets for retroviral mediated gene transfer owing to their quiescence, as retroviral transduction requires that the target cells be cycling. To try and surmount this problem we have constructed a retroviral producer line that expresses the membrane-bound form of human stem cell factor (SCF) on its cell surface. These cells are capable, therefore, of delivering a growth signal concomitant with recombinant retroviral vector particles. In this report we describe the use of this cell line to transduce a highly quiescent population of cells isolated from adult human bone marrow using the 5-fluorouracil (FU) resistance technique of Berardi et al. Quiescent cells selected using this technique were transduced by cocultivation with retroviral producers expressing surface bound SCF or with the parent cell line that does not. Following coculture, the cells were plated in long-term bone marrow culture for a further 5 weeks, before plating the nonadherent cells in semisolid media. Colonies forming in the semisolid media over the next 14 days were analyzed by polymerase chain reaction for the presence of the retroviral vector genome. Over six experiments, the transduction frequency of the quiescent 5-FU resistant cells using the SCF-expressing producer line averaged about 20%, whereas those transduced using the parent producer line showed evidence of reduced levels or no transduction.</abstract><cop>Washington, DC</cop><pub>The Americain Society of Hematology</pub><pmid>9834213</pmid><doi>10.1182/blood.V92.11.4080</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 1998-12, Vol.92 (11), p.4080-4089
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_V92_11_4080
source ScienceDirect - Connect here FIRST to enable access
subjects Adult
Antimetabolites, Antineoplastic - pharmacology
Biological and medical sciences
Biotechnology
Bone Marrow Cells - cytology
Bone Marrow Cells - physiology
Drug Resistance, Neoplasm
Fluorouracil - pharmacology
Fundamental and applied biological sciences. Psychology
Gene therapy
Gene Transfer Techniques
Genetic Vectors
Health. Pharmaceutical industry
Hematopoietic Stem Cells - cytology
Hematopoietic Stem Cells - drug effects
Hematopoietic Stem Cells - physiology
Humans
Industrial applications and implications. Economical aspects
Retroviridae
title Enhanced retroviral transduction of 5-fluorouracil-resistant human bone marrow (stem) cells using a genetically modified packaging cell line
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T12%3A04%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhanced%20retroviral%20transduction%20of%205-fluorouracil-resistant%20human%20bone%20marrow%20(stem)%20cells%20using%20a%20genetically%20modified%20packaging%20cell%20line&rft.jtitle=Blood&rft.au=POVEY,%20J&rft.date=1998-12-01&rft.volume=92&rft.issue=11&rft.spage=4080&rft.epage=4089&rft.pages=4080-4089&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood.V92.11.4080&rft_dat=%3Cpubmed_cross%3E9834213%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1723-b98cf0b32a3e2a9c3a10dda05a86e4f848eefaa5802d2596844e71c184cf680a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/9834213&rfr_iscdi=true